These results indicated that HOXC6 mRNA expression might be linked with poor clinical prognosis and are consistent with previous studies, which were conducted in GC and other malignant tumors such as prostate cancer, esophageal cancer and hepatocellular carcinoma [20, 22, 25, 26]. The gene discussed is HOXC6; the disease is hepatocellular carcinoma.